Truist Securities Maintains Buy on Vericel, Lowers Price Target to $42

Benzinga Newsdesk www.benzinga.com Negative 57.5%

Neg 57.5% Neu 0% Pos 0%

Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $48 to $42.